| Bioactivity | (R)-RP-6306 can be used for the research of Myt1 mediated diseases and kinds of cancer for slowing the progression of cancer[1]. (R)-RP-6306 (IC50=1360nM) is less active than (S)-RP-6306 (IC50<10nM). | ||||||||||||
| Name | (R)-RP-6306 | ||||||||||||
| CAS | 2719793-91-4 | ||||||||||||
| Formula | C18H20N4O2 | ||||||||||||
| Molar Mass | 324.38 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Daniel Durocher, et al. Methods of using myt1 inhibitors. Pantent WO2021195782A1. |
(R)-RP-6306
CAS: 2719793-91-4 F: C18H20N4O2 W: 324.38
(R)-RP-6306 can be used for the research of Myt1 mediated diseases and kinds of cancer for slowing the progression of ca
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.